• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病中性粒细胞减少患者由草绿色链球菌引起的败血症。

Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.

作者信息

Cohen J, Donnelly J P, Worsley A M, Catovsky D, Goldman J M, Galton D A

出版信息

Lancet. 1983;2(8365-66):1452-4. doi: 10.1016/s0140-6736(83)90799-7.

DOI:10.1016/s0140-6736(83)90799-7
PMID:6140545
Abstract

10 neutropenic leukaemic patients had septicaemia caused by viridans streptococci, organisms not commonly recognised as opportunist pathogens. 1 patient died; in the remainder recovery was generally dependent on an adequate circulating granulocyte count (seven patients) rather than specific antimicrobial therapy. Seven of the infections were caused by Streptococcus mitis, and seven of the eight strains tested were resistant to cotrimoxazole, which the patients had received as prophylaxis against infection. It is suggested that oral ulceration caused by cytotoxic chemotherapy provided a portal of entry for cotrimoxazole-resistant viridans streptococci. The increasing incidence of infections with gram-positive organisms as a complication of neutropenia prompts a reconsideration of current empirical antimicrobial therapy.

摘要

10名中性粒细胞减少的白血病患者发生了由草绿色链球菌引起的败血症,这类微生物通常不被视为机会性病原体。1例患者死亡;其余患者的康复通常取决于足够的循环粒细胞计数(7例患者),而非特异性抗菌治疗。7例感染由缓症链球菌引起,所检测的8株菌株中有7株对复方新诺明耐药,而这些患者此前一直服用复方新诺明预防感染。提示细胞毒性化疗引起的口腔溃疡为耐复方新诺明的草绿色链球菌提供了侵入途径。革兰氏阳性菌感染作为中性粒细胞减少的并发症,其发生率不断增加,这促使人们重新审视当前的经验性抗菌治疗。

相似文献

1
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.白血病中性粒细胞减少患者由草绿色链球菌引起的败血症。
Lancet. 1983;2(8365-66):1452-4. doi: 10.1016/s0140-6736(83)90799-7.
2
Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.甲氧苄啶-磺胺甲恶唑预防中性粒细胞减少患者感染。欧洲癌症研究与治疗组织国际抗菌治疗项目组。
J Infect Dis. 1984 Sep;150(3):372-9. doi: 10.1093/infdis/150.3.372.
3
Infections caused by viridans streptococci in patients with neutropenia.中性粒细胞减少患者由草绿色链球菌引起的感染。
Clin Infect Dis. 2002 Jun 1;34(11):1524-9. doi: 10.1086/340402. Epub 2002 May 6.
4
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.在未经挑选的急性髓系白血病患者群体中,草绿色链球菌引起的菌血症发病率增加。
Scand J Infect Dis. 2000;32(6):615-21. doi: 10.1080/003655400459513.
5
[Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].[恶性血液病无发热性中性粒细胞减少患者使用复方新诺明的预防性对照试验]
Sangre (Barc). 1982;27(5):912-8.
6
The importance of surveillance stool cultures during periods of severe neutropenia.严重中性粒细胞减少期进行粪便培养监测的重要性。
Infect Control. 1987 Aug;8(8):317-9. doi: 10.1017/s0195941700066406.
7
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.口服甲氧苄啶/磺胺甲恶唑用于预防急性白血病诱导化疗后的感染。
Am J Med. 1984 Oct;77(4):663-6. doi: 10.1016/0002-9343(84)90359-0.
8
Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.肿瘤血液学患者草绿色链球菌败血症的预防:青霉素G与复方新诺明疗效的对照比较研究
Ann Hematol. 1992 Jun;64(6):260-5. doi: 10.1007/BF01695467.
9
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.使用萘啶酸或甲氧苄啶-磺胺甲恶唑进行选择性肠道去污以预防中性粒细胞减少的癌症患者感染:疗效与抗菌谱及给药时间的关系。
Antimicrob Agents Chemother. 1987 Apr;31(4):551-7. doi: 10.1128/AAC.31.4.551.
10
Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).万古霉素联合庆大霉素及复方新诺明用于预防中性粒细胞减少的癌症患者感染(一项对照、安慰剂对照的前瞻性研究)
Eur J Cancer Clin Oncol. 1981 Dec;17(12):1315-22. doi: 10.1016/0014-2964(81)90014-1.

引用本文的文献

1
MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients.MASCC/ISOO 临床实践指南:口腔黏膜炎管理-儿科癌症患者口腔黏膜炎管理当前干预措施的亚分析。
Support Care Cancer. 2021 Jul;29(7):3539-3562. doi: 10.1007/s00520-020-05803-4. Epub 2020 Nov 6.
2
Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis.牙周炎及其在草绿色链球菌菌血症和感染性心内膜炎中的作用评估。
Indian Heart J. 2018 Mar-Apr;70(2):225-232. doi: 10.1016/j.ihj.2017.06.019. Epub 2017 Jul 1.
3
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
接受10天阿扎胞苷方案治疗的急性髓系白血病和骨髓增生异常综合征患者的感染并发症模式
Cancer Med. 2017 Dec;6(12):2814-2821. doi: 10.1002/cam4.1231. Epub 2017 Oct 23.
4
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.从癌症中性粒细胞减少患者血液中分离出的草绿色链球菌的分子关系及抗菌药敏性
J Clin Microbiol. 1999 Jun;37(6):1876-80. doi: 10.1128/JCM.37.6.1876-1880.1999.
5
E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.用于草绿色链球菌抗菌药物敏感性试验的E试验与琼脂稀释法比较
J Clin Microbiol. 1999 Jan;37(1):26-30. doi: 10.1128/JCM.37.1.26-30.1999.
6
Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway.缓症链球菌细胞壁和脂多糖通过肿瘤坏死因子依赖性途径在D-半乳糖胺致敏小鼠中诱导致死性。
Infect Immun. 1996 May;64(5):1846-9. doi: 10.1128/iai.64.5.1846-1849.1996.
7
Defining antibody targets in Streptococcus oralis infection.确定口腔链球菌感染中的抗体靶点。
Infect Immun. 1996 May;64(5):1600-8. doi: 10.1128/iai.64.5.1600-1608.1996.
8
Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.评估青霉素G在接受细胞毒性化疗的急性髓细胞白血病患者预防链球菌败血症中的作用。
Eur J Clin Microbiol Infect Dis. 1993 Oct;12(10):750-5. doi: 10.1007/BF02098462.
9
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.针对接受环丙沙星治疗的中性粒细胞减少患者的草绿色链球菌血培养分离株,潜在治疗性和预防性抗生素的活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2493-5. doi: 10.1128/AAC.37.11.2493.
10
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.自体骨髓移植患者在标准抗菌预防基础上加用革兰氏阳性菌预防的随机试验。
Antimicrob Agents Chemother. 1994 Mar;38(3):576-9. doi: 10.1128/AAC.38.3.576.